DPM Map for boe_tSR19.00.04.05

AddressLabelMetricsData TypePeriod Typeeba_dim:APLeba_dim:BASeba_dim:FBSeba_dim:MCGeba_dim:MCYeba_dim:PFSeba_dim:RPR
r0.170boe_a813.root/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstantN/AN/Aeba_IM:x12N/AN/AN/Aboe_eba_RP:x6004
r0.175boe_a813.root/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstantN/AN/Aeba_IM:x12N/AN/Aeba_IM:x16boe_eba_RP:x6004
010.170Debt securities/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x686eba_BA:x6eba_IM:x12eba_MC:x409eba_MC:x60N/Aboe_eba_RP:x6004
010.175Debt securities/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x686eba_BA:x6eba_IM:x12eba_MC:x409eba_MC:x60eba_IM:x16boe_eba_RP:x6004
070.170Loans and advances/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x686eba_BA:x6eba_IM:x12eba_MC:x409eba_MC:x469N/Aboe_eba_RP:x6004
070.175Loans and advances/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x686eba_BA:x6eba_IM:x12eba_MC:x409eba_MC:x469eba_IM:x16boe_eba_RP:x6004
180.170DEBT INSTRUMENTS AT COST OR AT AMORTISED COST/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x686eba_BA:x6eba_IM:x12eba_MC:x409eba_MC:x223N/Aboe_eba_RP:x6004
180.175DEBT INSTRUMENTS AT COST OR AT AMORTISED COST/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x686eba_BA:x6eba_IM:x12eba_MC:x409eba_MC:x223eba_IM:x16boe_eba_RP:x6004
181.170Debt securities/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x687eba_BA:x6eba_IM:x12eba_MC:x409eba_MC:x60N/Aboe_eba_RP:x6004
181.175Debt securities/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x687eba_BA:x6eba_IM:x12eba_MC:x409eba_MC:x60eba_IM:x16boe_eba_RP:x6004
191.170Loans and advances/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x687eba_BA:x6eba_IM:x12eba_MC:x409eba_MC:x469N/Aboe_eba_RP:x6004
191.175Loans and advances/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x687eba_BA:x6eba_IM:x12eba_MC:x409eba_MC:x469eba_IM:x16boe_eba_RP:x6004
201.170DEBT INSTRUMENTS AT FAIR VALUE THROUGH OTHER COMPREHENSIVE INCOME OR THROUGH EQUITY SUBJECT TO IMPAIRMENT/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x687eba_BA:x6eba_IM:x12eba_MC:x409eba_MC:x223N/Aboe_eba_RP:x6004
201.175DEBT INSTRUMENTS AT FAIR VALUE THROUGH OTHER COMPREHENSIVE INCOME OR THROUGH EQUITY SUBJECT TO IMPAIRMENT/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x687eba_BA:x6eba_IM:x12eba_MC:x409eba_MC:x223eba_IM:x16boe_eba_RP:x6004
211.170Debt securities/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x688eba_BA:x6eba_IM:x12eba_MC:x409eba_MC:x60N/Aboe_eba_RP:x6004
211.175Debt securities/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x688eba_BA:x6eba_IM:x12eba_MC:x409eba_MC:x60eba_IM:x16boe_eba_RP:x6004
221.170Loans and advances/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x688eba_BA:x6eba_IM:x12eba_MC:x409eba_MC:x469N/Aboe_eba_RP:x6004
221.175Loans and advances/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x688eba_BA:x6eba_IM:x12eba_MC:x409eba_MC:x469eba_IM:x16boe_eba_RP:x6004
231.170DEBT INSTRUMENTS AT FAIR VALUE THROUGH PROFIT AND LOSS OR THROUGH EQUITY NOT SUBJECT TO IMPAIRMENT/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x688eba_BA:x6eba_IM:x12eba_MC:x409eba_MC:x223N/Aboe_eba_RP:x6004
231.175DEBT INSTRUMENTS AT FAIR VALUE THROUGH PROFIT AND LOSS OR THROUGH EQUITY NOT SUBJECT TO IMPAIRMENT/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x688eba_BA:x6eba_IM:x12eba_MC:x409eba_MC:x223eba_IM:x16boe_eba_RP:x6004
330.170DEBT INSTRUMENTS OTHER THAN HELD FOR TRADING OR TRADING/Collateral received on exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x77eba_BA:x6eba_IM:x12eba_MC:x409eba_MC:x223N/Aboe_eba_RP:x6004
330.175DEBT INSTRUMENTS OTHER THAN HELD FOR TRADING OR TRADING/Of which: Collateral received on non-performing exposures with forbearance measureseba_met:mi339xbrli:monetaryItemTypeinstanteba_PL:x77eba_BA:x6eba_IM:x12eba_MC:x409eba_MC:x223eba_IM:x16boe_eba_RP:x6004